LLY
768.15
+2.94%↑
JNJ
176.55
-0.3%↓
ABBV
216.89
+0.98%↑
UNH
341.7
-2.13%↓
AZN
77.95
+0.22%↑
LLY
768.15
+2.94%↑
JNJ
176.55
-0.3%↓
ABBV
216.89
+0.98%↑
UNH
341.7
-2.13%↓
AZN
77.95
+0.22%↑
LLY
768.15
+2.94%↑
JNJ
176.55
-0.3%↓
ABBV
216.89
+0.98%↑
UNH
341.7
-2.13%↓
AZN
77.95
+0.22%↑
LLY
768.15
+2.94%↑
JNJ
176.55
-0.3%↓
ABBV
216.89
+0.98%↑
UNH
341.7
-2.13%↓
AZN
77.95
+0.22%↑
LLY
768.15
+2.94%↑
JNJ
176.55
-0.3%↓
ABBV
216.89
+0.98%↑
UNH
341.7
-2.13%↓
AZN
77.95
+0.22%↑
24h
Šī brīža
Min
36
Max
37.75
Rekomendācijas | Pirkt |
---|---|
Prognoze 12 mēnešiem | +13.94% upside |
Nākamie ieņēmumi | 2025. g. 6. nov. |
---|
By Acuity
50%
50%
183 / 371 Rangs Healthcare
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
2025. g. 15. sept. 22:39 UTC
CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer
DJ
Lasīt
2025. g. 15. sept. 16:43 UTC
Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy
DJ
Lasīt
2025. g. 15. sept. 16:42 UTC
Helius Medical Tech Jumps on Funding to Launch Solana Treasury
DJ
Lasīt
2025. g. 15. sept. 16:35 UTC
Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process
DJ
Lasīt
2025. g. 15. sept. 23:46 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2025. g. 15. sept. 23:46 UTC
Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 23:34 UTC
Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 22:48 UTC
FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 22:12 UTC
CSL Expects Commercial Launch in 2029
DJ
Lasīt
2025. g. 15. sept. 22:12 UTC
CSL Says VarmX to Receive Further Commercial Milestones Afterwards
DJ
Lasīt
2025. g. 15. sept. 22:11 UTC
CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001
DJ
Lasīt
2025. g. 15. sept. 22:11 UTC
CSL to Have Right to Exercise Option Based on Phase 3 Data
DJ
Lasīt
2025. g. 15. sept. 22:10 UTC
CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company
DJ
Lasīt
2025. g. 15. sept. 21:16 UTC
Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital
DJ
Lasīt
2025. g. 15. sept. 21:16 UTC
Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development
DJ
Lasīt
2025. g. 15. sept. 21:15 UTC
Chord Energy to Buy 48,000 Net Acres in the Williston Core
DJ
Lasīt
2025. g. 15. sept. 21:14 UTC
Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M
DJ
Lasīt
2025. g. 15. sept. 20:50 UTC
Auto & Transport Roundup: Market Talk
DJ
Lasīt
2025. g. 15. sept. 20:50 UTC
Financial Services Roundup: Market Talk
DJ
Lasīt
2025. g. 15. sept. 20:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
2025. g. 15. sept. 19:29 UTC
U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 19:14 UTC
Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 18:16 UTC
Gold Powers to New High -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 18:05 UTC
Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 17:50 UTC
U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update
DJ
Lasīt
2025. g. 15. sept. 17:10 UTC
Global Forex and Fixed Income Roundup: Market Talk
DJ
Lasīt
2025. g. 15. sept. 17:10 UTC
S&P Expects Fed, BOC to Cut Rates -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 16:52 UTC
Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk
DJ
Lasīt
2025. g. 15. sept. 16:20 UTC
Financial Services Roundup: Market Talk
DJ
Lasīt
2025. g. 15. sept. 16:20 UTC
Auto & Transport Roundup: Market Talk
DJ
Lasīt
Cenas izmaiņa
By TipRanks
Prognoze 12 mēnešiem
Vidējais 42.5 USD 13.94%
Augstākais 67 USD
Zemākais 23 USD
Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Rigel Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.
By TipRanks
Pirkt
4 ratings
2
Pirkt
2
Turēt
0
Pārdot
Pamatojoties uz 4 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Rigel Pharmaceuticals Inc — pēdējo 3 mēnešu laikā.
By Acuity
Ziņu noskaņojums
Neutral
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Zem vidējā
$